Author:
Larsson Susanna C.,Wang Lijuan,Li Xue,Jiang Fangyuan,Chen Xiangjun,Mantzoros Christos S.
Funder
Forskningsrådet om Hälsa, Arbetsliv och Välfärd
National Institutes of Health
Science Fund for Distinguished Young Scholars of Zhejiang Province
National Natural Science Foundation of China
Cancerfonden
Vetenskapsrådet
Hjärt-Lungfonden
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference21 articles.
1. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies;Tsimikas;J Am Coll Cardiol,2017
2. Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies: a Mendelian randomization analysis;Burgess;JAMA Cardiol,2018
3. Lipoprotein(a) concentration and risks of cardiovascular disease and diabetes;Gudbjartsson;J Am Coll Cardiol,2019
4. Phenotypic characterization of genetically lowered human lipoprotein(a) levels;Emdin;J Am Coll Cardiol,2016
5. Lipoprotein(a) in alzheimer, atherosclerotic, cerebrovascular, thrombotic, and valvular disease: Mendelian randomization investigation;Larsson;Circulation,2020
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献